» Articles » PMID: 23978545

Women, Kidney Disease, and Pregnancy

Overview
Specialty Nephrology
Date 2013 Aug 28
PMID 23978545
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Several glomerular diseases may occur in women of childbearing age. Pregnancy in such patients should be planned when the disease has been in remission for a minimum of 6 months to minimize maternal and fetal complications. Immunosuppressive agents should be optimized before conception to include those that are safe for pregnancy. The complexity of medical management when caring for these patients calls for a multidisciplinary team approach consisting of a nephrologist, rheumatologist, obstetrician, and pharmacist. This review will address the physiological changes of pregnancy that may affect glomerular disease presentation, activity, and diagnosis; specific glomerular diseases primary and secondary to systemic diseases in the context of pregnancy; fetal and maternal complications and long-term effects; diagnosis and differential diagnosis; and treatment strategies that are considered relatively safe with respect to fetal intrauterine exposure.

Citing Articles

Pre-gestational counselling for women living with CKD: starting from the bright side.

Da Silva I, Orozco-Guillen A, Longhitano E, Ballarin J, Piccoli G Clin Kidney J. 2024; 17(5):sfae084.

PMID: 38711748 PMC: 11070880. DOI: 10.1093/ckj/sfae084.


Kidney diseases in women: difference in risks and opportunities.

Mastroianni Kirsztajn G, Moura A, Rodrigues C, Sanders-Pinheiro H, Moura-Neto J, Mansur J Rev Assoc Med Bras (1992). 2023; 69(suppl 1):e2023S117.

PMID: 37556636 PMC: 10411704. DOI: 10.1590/1806-9282.2023S117.


Maternal fructose intake during pregnancy and lactation: Later effects on renal function.

Monteiro L, Barbosa C, Lichtenecker D, Argeri R, Gomes G Physiol Rep. 2022; 10(18):e15470.

PMID: 36117297 PMC: 9483175. DOI: 10.14814/phy2.15470.


Maternal and fetal outcomes of pregnancy in chronic kidney disease: diagnostic challenges, surveillance and treatment throughout the spectrum of kidney disease.

Gouveia I, Silva J, Santos C, Carvalho C J Bras Nefrol. 2021; 43(1):88-102.

PMID: 33460427 PMC: 8061969. DOI: 10.1590/2175-8239-JBN-2020-0055.


Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era.

Colla L, Diena D, Rossetti M, Manzione A, Marozio L, Benedetto C J Nephrol. 2018; 31(3):361-383.

PMID: 29476421 DOI: 10.1007/s40620-018-0477-3.


References
1.
Bansal P, Tobin M . Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol. 2004; 93(4):398-401. DOI: 10.1016/S1081-1206(10)61400-7. View

2.
DAgati V, Kaskel F, Falk R . Focal segmental glomerulosclerosis. N Engl J Med. 2011; 365(25):2398-411. DOI: 10.1056/NEJMra1106556. View

3.
Leisti S, KOSKIMIES O . Risk of relapse in steroid-sensitive nephrotic syndrome: effect of stage of post-prednisone adrenocortical suppression. J Pediatr. 1983; 103(4):553-7. DOI: 10.1016/s0022-3476(83)80582-4. View

4.
Fraser F, FAINSTAT T . Production of congenital defects in the off-spring of pregnant mice treated with cortisone; progress report. Pediatrics. 1951; 8(4):527-33. View

5.
Hod M, van Dijk D, Karp M, Weintraub N, Rabinerson D, Bar J . Diabetic nephropathy and pregnancy: the effect of ACE inhibitors prior to pregnancy on fetomaternal outcome. Nephrol Dial Transplant. 1995; 10(12):2328-33. DOI: 10.1093/ndt/10.12.2328. View